Skip to content

Dr. Geert Vanhooren

Active
Private limited companyfounded 2010active for 16 yearsTimmermansstraat 21, 8340 Damme, BelgiumKBO/BCE: BE 0828.322.788
Summary

Dr. Geert Vanhooren has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €658,293 and a net result of €85,784. Equity has been growing by about 19% per year since 2018. Its solvency ranks better than 89% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-07-2010 Normal situation
Activity
Specialist medical practice NACE 86220and 2 others
Establishment unit
2.190.548.426 8340 Damme, since 17-08-2010
Financial year end
31 December
Peppol
Reachable since 13-02-2024

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€127,884
▲ 34.6%
Turnover
≈ €240,000
estimated
Profit
€85,784
▲ 51.0%
Equity
€658,293
▲ 15.0%
Total assets
€703,349
▲ 13.8%
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €703,349Figures for financial year 2025 (filed on 22-07-2026)Equity €658,293 (93.6% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 54% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 93.6% of total assets
Liquidity 62-17
short-term debt 4.5% · cash 10.0%
Profitability 84+4
return on assets 12.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €60,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 21.29 (30.56 in 2024), above the usual 1.5. Short-term debt is 4.5% and cash 10% of total assets. 6.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 41% on liquidity, 33% on profitability and 58% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €703,349
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 22-07-2026)
NBB · annual accounts
lowers risk · Equity €658,293 (93.6% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
9 days early
2024
20 days early
2023
29 days late
2022
27 days early
2021
38 days early
2020
30 days late
2019
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 1 day before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 89% of companies in human healthsector median 63.0% · 20,720 companies 93.6% View
  • Positive: 8 profitable years in a rowprofit 2025: €85,784 8 years View

Recent changes

  1. · Gazette deed Change of role: VANHOOREN Geert Theopiel Omer, from manager to directorDirector discharge: VANHOOREN Geert Theopiel Omer
  2. · Gazette deed Incorporation
All 18 events

Comparable companies

These companies have the same main activity as Dr. Geert Vanhooren: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €666,000 and €755,000, founded between 2009 and 2010.

CompanyTotal assetsGross margin
Dr. Geert Vanhooren Damme€703,349€127,884
STÎNGACIU Sorin, HEMATOLOGIE Arlon€666,447€124,038
Docteur GUCCIARDO Léonardo - Gynécologie-Obstétrique Hannut€666,313€132,461
TSHIBANGU ANNIE Schaarbeek€718,122€120,648
Docteur Gaël Jacquemin Ciney€668,435€134,643
DOCTEUR FRANCOIS CARDINAL Watermaal-Bosvoorde€755,375€127,812
DOCTEURS PIERRE-LIPPENS Aubange€725,976€131,738
Full comparison

Key facts about Dr. Geert Vanhooren

What is the company number of Dr. Geert Vanhooren?
The company number of Dr. Geert Vanhooren is 0828.322.788. The VAT number is the same number with BE in front: BE 0828.322.788.
Where is Dr. Geert Vanhooren based?
The registered office is at Timmermansstraat 21, 8340 Damme.Company details
What does Dr. Geert Vanhooren do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Geert Vanhooren?
The legal form of Dr. Geert Vanhooren is Private limited company (BV).
When was Dr. Geert Vanhooren founded?
Dr. Geert Vanhooren was founded on 20-07-2010.
Is Dr. Geert Vanhooren still active?
Yes, Dr. Geert Vanhooren is an active enterprise in the KBO register.
What is the turnover of Dr. Geert Vanhooren?
The turnover in financial year 2025 is ≈ €240,000. This figure is estimated from the gross margin of €127,884 and 42 comparable companies (NACE 86220). It probably lies between €200,000 and €310,000.Financials
Is Dr. Geert Vanhooren profitable?
In financial year 2025, Dr. Geert Vanhooren made a profit of €85,784.
Where can I find the annual accounts of Dr. Geert Vanhooren?
Dr. Geert Vanhooren filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Geert Vanhooren due?
Dr. Geert Vanhooren must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.